Education
About Us
Working with TipRanks
Follow Us
William Wallen Insider Profile
4 Followers
William Wallen, Senior VP & CSO at Idexx Laboratories, holds 106.80K shares in Aspira Women's Health (Ticker: AWH), holds 20.06K shares in Idexx Laboratories (Ticker: IDXX).
William Wallen Idexx Laboratories (IDXX)Senior VP & CSO
Idexx Laboratories (IDXX)
Senior VP & CSO
Ranked #88,876 out of 100,956 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-38.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that William Wallen holds in companies
Most Profitable Insider Trade
The most profitable trade made by William Wallen
William Wallen's Trading History
Idexx Laboratories
Feb 17, 2010
Senior VP & CSO
Uninformative Buy
―
$8.63M
Aspira Women's Health
Dec 16, 2013
Former Director
Uninformative Buy
―
$19.76K
List of latest transactions for each holding click on a transaction to see William Wallen's performance on stock
You May Also Like
William Wallen insider profile FAQ
What is the percentage of profitable transactions made by William Wallen?
The percentage of profitable transactions made by William Wallen is 0%.
What is the average return per transaction made by William Wallen?
The average return per transaction made by William Wallen is -38.10%.
What stocks does William Wallen hold?
William Wallen holds: IDXX, AWH stocks.
What was William Wallen’s latest transaction?
William Wallen latest transaction was an Uninformative Buy of ―.
What was William Wallen's most profitable transaction?
William Wallen’s most profitable transaction was an Informative Sell of IDXX stock on August 25, 2009. The return on the trade was -9.50%.
What is William Wallen's role in Idexx Laboratories?
William Wallen's role in Idexx Laboratories is Senior VP & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.